GR851645B - - Google Patents

Info

Publication number
GR851645B
GR851645B GR851645A GR850101645A GR851645B GR 851645 B GR851645 B GR 851645B GR 851645 A GR851645 A GR 851645A GR 850101645 A GR850101645 A GR 850101645A GR 851645 B GR851645 B GR 851645B
Authority
GR
Greece
Application number
GR851645A
Inventor
Nariman Bomanshaw Mehta
Thomas Edgar Smyser
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR851645B publication Critical patent/GR851645B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/061,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
GR851645A 1984-07-05 1985-07-04 GR851645B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848417170A GB8417170D0 (en) 1984-07-05 1984-07-05 Heterocyclic pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GR851645B true GR851645B (el) 1985-11-26

Family

ID=10563453

Family Applications (1)

Application Number Title Priority Date Filing Date
GR851645A GR851645B (el) 1984-07-05 1985-07-04

Country Status (12)

Country Link
EP (1) EP0170430A1 (el)
JP (1) JPS6124578A (el)
KR (1) KR860001083A (el)
AU (1) AU4459585A (el)
DK (1) DK307385A (el)
ES (1) ES8609286A1 (el)
FI (1) FI852657L (el)
GB (1) GB8417170D0 (el)
GR (1) GR851645B (el)
HU (1) HUT39437A (el)
IL (1) IL75720A0 (el)
ZA (1) ZA855072B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8924528D0 (en) * 1989-10-31 1989-12-20 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
GB9108629D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Heterocyclic pharmaceutical compounds,preparation and use
NZ520349A (en) 1998-01-21 2004-02-27 Glaxo Group Ltd (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2- morpholinol and its salts and pharmaceuticals thereof
US7098206B2 (en) 1998-01-21 2006-08-29 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6998400B2 (en) 1998-01-22 2006-02-14 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6855820B2 (en) 1999-01-20 2005-02-15 Smithkline Beecham Corporation Pharmaceutically active morpholinol
US6734213B2 (en) 1999-01-20 2004-05-11 Smithkline Beecham Corporation Pharmaceutically active morpholinol
NZ561375A (en) 2005-06-27 2011-06-30 Biovail Lab Int Srl Bupropion hydrobromide, and crystalline forms, compositions, and uses of this compound
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법
ES2546492T3 (es) 2010-05-21 2015-09-24 Research Triangle Institute Derivados de 1-fenilmorfolina como análogos de hidroxibupropion para tratar drogodependencia
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117967A (en) * 1962-04-02 1964-01-14 Smith Kline French Lab 2-biphenylyl-2-hydroxy-morpholinium halides
FR2553413B1 (fr) * 1983-10-17 1986-03-21 Lafon Labor Derives de 4-alkyl-2-hydroxy-3-methyl-2-phenyl-morpholine, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
ES544862A0 (es) 1986-07-16
IL75720A0 (en) 1985-11-29
DK307385A (da) 1986-01-06
FI852657L (fi) 1986-01-06
KR860001083A (ko) 1986-02-22
DK307385D0 (da) 1985-07-04
JPS6124578A (ja) 1986-02-03
GB8417170D0 (en) 1984-08-08
EP0170430A1 (en) 1986-02-05
ZA855072B (en) 1987-02-25
FI852657A0 (fi) 1985-07-04
AU4459585A (en) 1986-01-09
HUT39437A (en) 1986-09-29
ES8609286A1 (es) 1986-07-16

Similar Documents

Publication Publication Date Title
DE8418475U1 (el)
GR851645B (el)
DE3430394C2 (el)
DE3425682C2 (el)
DE3410258C2 (el)
DE8431071U1 (el)
DE8408177U1 (el)
DE8402602U1 (el)
BG45158A1 (el)
BE900712A (el)
BG45296A1 (el)
BG45280A1 (el)
BG45279A1 (el)
BG45273A1 (el)
BG45272A1 (el)
BG45254A1 (el)
BG45245A1 (el)
BG45202A1 (el)
BG45182A1 (el)
BG45166A1 (el)
BG45165A1 (el)
BG45164A1 (el)
BG45163A1 (el)
BG45160A1 (el)
BG45181A1 (el)